229 related articles for article (PubMed ID: 19890022)
1. Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial.
Banaszewska B; Pawelczyk L; Spaczynski RZ; Duleba AJ
J Clin Endocrinol Metab; 2009 Dec; 94(12):4938-45. PubMed ID: 19890022
[TBL] [Abstract][Full Text] [Related]
2. Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment.
Banaszewska B; Pawelczyk L; Spaczynski RZ; Duleba AJ
J Clin Endocrinol Metab; 2011 Nov; 96(11):3493-501. PubMed ID: 21865358
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of combined simvastatin and metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome.
Seyam E; Hefzy E
Gynecol Endocrinol; 2018 Dec; 34(12):1073-1080. PubMed ID: 30044162
[TBL] [Abstract][Full Text] [Related]
4. Effect of Metformin Alone Compared with Metformin Plus Simvastatin on Polycystic Ovarian Syndrome in Pakistani Women.
Malik M; Tasnim N; Mahmud G
J Coll Physicians Surg Pak; 2018 Mar; 28(3):184-187. PubMed ID: 29544572
[TBL] [Abstract][Full Text] [Related]
5. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
6. Effects of metformin plus rosuvastatin on hyperandrogenism in polycystic ovary syndrome patients with hyperlipidemia and impaired glucose tolerance.
Celik O; Acbay O
J Endocrinol Invest; 2012 Nov; 35(10):905-10. PubMed ID: 22522778
[TBL] [Abstract][Full Text] [Related]
7. Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial.
Banaszewska B; Pawelczyk L; Spaczynski RZ; Dziura J; Duleba AJ
J Clin Endocrinol Metab; 2007 Feb; 92(2):456-61. PubMed ID: 17105841
[TBL] [Abstract][Full Text] [Related]
8. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
[TBL] [Abstract][Full Text] [Related]
9. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.
Kolodziejczyk B; Duleba AJ; Spaczynski RZ; Pawelczyk L
Fertil Steril; 2000 Jun; 73(6):1149-54. PubMed ID: 10856473
[TBL] [Abstract][Full Text] [Related]
10. Statins for women with polycystic ovary syndrome not actively trying to conceive.
Raval AD; Hunter T; Stuckey B; Hart RJ
Cochrane Database Syst Rev; 2011 Oct; (10):CD008565. PubMed ID: 21975784
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study.
Kaya C; Pabuccu R; Cengiz SD; Dünder I
Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):161-6. PubMed ID: 20146169
[TBL] [Abstract][Full Text] [Related]
12. Inadequacy of initiating rosuvastatin then metformin on biochemical profile of polycystic ovarian syndrome patients.
Ghazeeri G; Abbas HA; Skaff B; Harajly S; Awwad J
J Endocrinol Invest; 2015 Jun; 38(6):643-51. PubMed ID: 25722221
[TBL] [Abstract][Full Text] [Related]
13. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
Ye BL; Yang HY; Zhao JZ; Lin JJ; Lin WQ
Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846
[TBL] [Abstract][Full Text] [Related]
14. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
Mitkov M; Pehlivanov B; Terzieva D
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):93-8. PubMed ID: 16360262
[TBL] [Abstract][Full Text] [Related]
15. Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies.
Karakas SE; Banaszewska B; Spaczynski RZ; Pawelczyk L; Duleba A
Gynecol Endocrinol; 2013 May; 29(5):483-7. PubMed ID: 23480783
[TBL] [Abstract][Full Text] [Related]
16. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
[TBL] [Abstract][Full Text] [Related]
17. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of simvastatin plus metformin for polycystic ovary syndrome: A meta-analysis of randomized controlled trials.
Meng J; Zhu Y
Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():19-24. PubMed ID: 33338947
[TBL] [Abstract][Full Text] [Related]
19. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
20. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
